AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
YD Bio showcased its diagnostic and precision medicine portfolios at the 9th Healthcare EXPO Taiwan, highlighting its DNA methylation-based cancer detection technology and ophthalmologic innovations. The company received positive feedback from attendees, engaged in productive discussions with international distributors, and met with key opinion leaders from major hospitals in Asia. YD Bio aims to expand global access to precision cancer detection and preventive healthcare solutions.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet